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A B S T R A C T   
Colorectal cancer remains a challenging health burden worldwide. This study aimed to assess the potentiality of 
Strawberry tree honey (STH), a polyphenol-enriched food, to increase the effectiveness of 5-Fluorouracil (5-FU) 
in adenocarcinoma (HCT-116) and metastatic (LoVo) colon cancer cell lines. The combined treatment reduced 
cell viability and caused oxidative stress, by increasing oxidative biomarkers and decreasing antioxidant defence, 
in a more potent way compared to 5-FU alone. The expression of endoplasmic reticulum (ATF-6, XBP-1) and 
MAPK (p-p38 MAPK, p-ERK1/2) markers were also elevated after the combined treatment, enhancing the cell 
cycle arrest through the modulation of regulatory genes (i.e., cyclins and CDKs). Apoptotic gene (i.e., caspases) 
expressions were also increased after the combined treatment, while those of proliferation (i.e., EGFR), cell 
migration, invasion (i.e., matrix metallopeptidase) and epithelial–mesenchymal transition (N-cadherin, β-cat-
enin) were suppressed. Finally, the combined treatment led cell metabolism towards a quiescent stage, by 
reducing mitochondrial respiration and glycolysis. In conclusion, this work represents an initial step to highlight 
the possibility to use STH in combination with 5-FU in the treatment of colon cancer, even if further in vitro an in 
vivo studies are strongly needed to confirm the possible chemo-sensitizing effects of STH.   
1. Introduction 
Worldwide, colorectal cancer (CRC) is the third most deadly diseases 
due to the lack of efficient treatment, unfavorable side effects and 
therapeutic resistance. Depending on the patient condition and the 
cancer stage, chemotherapeutics are selected alone or as adjuvants 
(Schmoll et al., 2012), but with them more than 50% patients will 
persistent the disease (Jemal et al., 2009). 5-Fluorouracil (5-FU) is the 
most commonly used anti-cancer agent, but its application reduces less 
than 50% of patient’s responses at an early stage of CRC; additionally, its 
activity increases when it is combined with other anti-cancer drugs, but 
with adverse toxicity and highly therapeutic resistance in later stage 
(González-Vallinas et al., 2013). In order to increase the effectiveness of 
5-FU and overcome chemo resistance and toxicity effects, a new 
approach is necessary based on the application of nutritionally rich 
foods or isolated bioactive compounds. In several studies, the synergistic 
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and additive effects of phenolic compounds on different cancer models 
have already been examined (Liu, 2004); from this point of view, it 
could be helpful to use the whole food products and not only isolated 
compounds because of the intake facility and complex mixture of 
nutritive and non-nutritive bioactive compounds. 
Diet has a significant impact on CRC, since there is an inverse rela-
tionship between polyphenol-rich food and colon cancer incidence 
(Núñez-Sánchez et al., 2015). Recently, there has been rising attention 
on the search and application of natural food or isolated compounds due 
to their advantage of effective pharmacological activities and safety 
(Núñez-Sánchez et al., 2015). Targeting different cancer models, natural 
products may affect several oncogenic pathways related to proliferation, 
inflammation, cell cycle, apoptosis, invasion, angiogenesis and metas-
tasis (Lee et al., 2011; Cianciosi et al., 2020; Battino et al., 2021). 
Strawberry tree (Arbutus unedo L.) honey (STH) is a typical product from 
the Mediterranean area; however, to date no study has evaluated the 
chemo-sensitizing effects of STH in colon cancer cells. STH contains 
several phenolic acids and flavonols, including gallic acid, 4-hydroxy-
benzoic acid, protocatechuic acid, caffeic acid, vanillic acid, kaemp-
ferol, quercetin, luteolin and myricetin (Afrin et al., 2019b). 
Additionally, the antioxidant capacity of STH is higher compared to the 
well-known Manuka honey (Afrin et al., 2017). STH induces anti-cancer 
effects in colon cancer cells by decreasing cell proliferation, arresting 
cell cycle, activating apoptosis, increasing ROS, altering metabolic 
phenotype and suppressing metastasis ability, whereas in healthy cells it 
didn’t exert any toxic effects (Afrin et al., 2019a, 2019b). The current 
work aimed to investigate the chemo-sensitizing effects of STH in 
combination with 5-FU on human colon HCT-116 and LoVo cancer cell 
lines. 
2. Materials and methods 
2.1. Reagents, chemicals and antibodies 
Reagents and chemicals used for the experimental purposed were 
purchased from Sigma-Aldrich (Milan, Italy), while all the media and 
other reagents for cell culture were obtained from Carlo Erba Reagents 
(Milan, Italy). STH samples, a kind gift of Prof. Gavino Sanna (Depart-
ment of Chemistry and Pharmacy at the University of Sassari, Italy) were 
preserved at 4 ◦C until used. All the primary antibodies (i.e., activating 
transcription factor 6 (ATF6), X-box-binding protein 1 (XBP1), nuclear 
factor erythroid 2-related factor 2 (Nrf2), phosphorylated inhibitor of 
kappa B (p-IκBα), nuclear factor κB (NF-κB), heme oxygenase 1 (HO-1), 
catalase (CAT), superoxide dismutase (SOD), p53, caspase-3, cleaved- 
poly (ADP-ribose) polymerase (c-PARP), human epidermal growth fac-
tor receptor 2 (HER2), epidermal growth factor receptor (EGFR), p- 
mammalian target of rapamycin (p-mTOR), phosphorylated protein ki-
nase B (p-Akt), p-mitogen activated protein kinase (p-p38 MAPK), p- 
extracellular-signal regulated kinase 1/2 (p-Erk1/2), matrix metal-
loproteinases 2 (MMP-2), MMP-9, N-cadherin, β-catenin, E-cadherin, 
and glyceraldehyde-3-phosphate dehydrogenase (GADPH)) were pur-
chased from Santa Cruz Biotechnology (Dallas, TX, USA). 
Human colon carcinoma cell lines HCT-116 (organ: colon, disease: 
colorectal adenocarcinoma) and LoVo (organ: colon, disease: Dukes’ 
type C, grade IV, colon metastasis) were obtained from American Type 
Culture Collection (ATCC). 
2.2. Cell culture and proliferation assay 
HCT-116 cell line was grown in McCoy’s 5 A medium supplemented 
with 10% FBS and 1% antibiotic, while LoVo cell line was grown in 
F–12 K medium supplemented with 10% FBS and 1% antibiotic. 
Adherent monolayer cells were maintained at 37 ◦C in a humidified 
atmosphere of 5% CO2 under standard conditions. Cultured HCT-116 
and LoVo cells were treated with different concentrations of STH and 
5- FU for 48 h respectively in order to find the IC50 concentration by 
MTT assay (Afrin et al., 2019b). SHT was filtered with a MF-Millipore™ 
Membrane Filter (0.45 μm pore size) and dissolved into each specific 
medium. The synergistic or additive effect of STH on 5-FU was deter-
mined by the combination index (CI) as explained in our previous paper 
(Afrin et al., 2018). For the subsequent experiment cells were treated 
with (i) only media (CTL group), (ii) IC50 of STH, (iii) IC50 of 5-FU and 
(iv) IC50 of STH+5-FU combination. 
2.3. Determination of intracellular ROS levels, TBARS and protein 
carbonyl content, and antioxidant enzyme activity 
The Cell ROX® Oxidative Stress kit (Invitrogen™, Life Technologies, 
Milan, Italy) was used for determining the intracellular reactive oxygen 
species (ROS) generation by Tali® Image-Based cytometer (Invi-
trogen™, Life Technologies, Milan, Italy) after STH treatment, as 
explained in et al., 2019. Results are expressed as % compared to control 
cells. 
Cellular lysates were obtained using RIPA buffer (Sigma-Aldrich, 
Milan, Italy) at the end of the treatment and were used for determining 
the levels of oxidative biomarkers and the activities of the antioxidant 
enzymes. Thiobarbituric acid-reactive substance (TBARS), protein 
carbonyl content and antioxidant enzymes CAT, SOD, glutathione 
peroxidase (GPx), glutathione reductase (GR) and glutathione S-trans-
ferases (GST) were measured through spectrophotometric methods as 
earlier reported by our group (Giampieri et al., 2017). The results of 
TBAR and carbonyl group were measured as mmol/mg of protein and 
expressed as % compared to control cells, while SOD-1, CAT, GPx, GR 
and GST activities were measured as unit/mg protein and expressed as % 
compared to control cells. 
2.4. Cell cycle analysis 
The Tali® Cell Cycle Kit (Invitrogen™, Life Technologies, Milan, 
Italy) was used for analyzing the cell cycle assay after the exposure of 
different treatment groups (Afrin et al., 2019b). The cellular pellets were 
fixed with 70% ethanol and reading by Tali™ Image-Based Cytometer 
after re-suspending with 100 μL PBS containing 20 μg/mL propidium 
iodide (Invitrogen™, Life Technologies, Milan, Italy), 0.2 mg/mL RNase 
A and 0.1% Triton® X-100 (Invitrogen). Results are expressed as fold 
change compared to control cells. 
2.5. Determination of apoptotic rate 
Tali™ Apoptosis Assay Kit–Annexin V Alexa Fluor® 488 (Invi-
trogen™, Life Technologies, Milan, Italy) kit was used for the determi-
nation of apoptosis cells by Tali™ Image-Based Cytometer (Afrin et al., 
2019b). Results are expressed as fold change compared to control cells. 
2.6. RNA isolation and real-time PCR 
PureLink® RNA Mini Kit (Invitrogen, Carlsbad, CA, USA) was used 
for isolating total RNA content according to the manufacturer’s proto-
col. cDNA was synthesized following reverse transcription by using 5 ×
All-In-One RT MasterMix kit (Applied Biological Materials Inc. Canada). 
Real-time PCR was performed using EvaGreen 2× qPCRMaster Mix 
(Applied Biological Materials Inc. Canada) of forward and reverse 
primers (Supplementary Table 1) for p53, Caspase-3, 8, 9, c-PARP, Bcl-2, 
Bax, Cyt C, Fas L, Cyclin D1, E, CDK2, CDK4, p21waf1/cip 1, p27kip1, p- 
Rb genes; 2‒ΔΔct method was used for calculating the fold change values 
after normalizing the data (Afrin et al., 2019b). 
2.7. Determination of energetic metabolism 
The baseline metabolic phenotype of each cell was determined by 
using basal values of oxygen consumption rate (OCR) and extracellular 
acidification rate (ECAR) by using an Agilent Seahorse XF24 Analyzer 
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(Seahorse Bioscience, North Billerica, MA, USA), as previously described 
in our paper (Afrin et al., 2019a). OCR was expressed in picomo-
les/minute (pmole/min) per 3.0 × 104 cells and ECAR was stated in 
milli-pH/minute (mpH/min) per 3.0 × 104 cells. 
2.8. In vitro scratch assay 
In vitro scratch assay was carried out according to the previous 
method described by our group (Afrin et al., 2019a). At the end of the 
treatment, the scratch areas were analyzed by NIH Image J software. 
2.9. Western blotting analysis 
Cells proteins were isolated by using lysing buffer (120 mmol/L 
NaCl, 40 mmol/L Tris [pH 8], 0.1% NP40) containing protease in-
hibitors and measured by Bradford protein assay. Western blot analyses 
were performed as described in our paper (Afrin et al., 2019b). The blots 
were assessed through a chemiluminescence method (C-DiGit Blot 
Scanner, LICOR, Bad Homburg, Germany) and the band intensity was 
measured through image studio digits software 3.1 (C-DiGit Blot Scan-
ner, LICOR, Bad Homburg, Germany). 
2.10. Statistical analysis 
Statistical analysis was carried out through the software STATISTICA 
(Statsoft Inc., Tulsa, OK, USA). All the results are expressed as mean ±
SD of triplicate experiments. Significance differences between the means 
of groups were statistically performed by one-way analysis of variance 
(ANOVA) and by Tukey’s honestly significant difference (HSD) post hoc 
test. The level of the significance for all test set at *P < 0.05, **P < 0.01 
and ***P < 0.0001, compared to the control group. 
3. Results 
3.1. STH sensitizes colon cancer cells to 5-FU-treatment decreasing cell 
viability 
The cytotoxic activity of STH and 5-FU was screened alone or in 
combination in HCT-116 cells and LoVo cells by MTT assay after 48 h 
incubation (Table 1). 
In HCT-116 cells, 3–12 mg/mL concentrations were chosen for the 
STH (Afrin et al., 2019b) and 5–50 μM concentrations were selected for 
5-FU treatments. In LoVo cells, the concentrations were higher because 
of its metastatic nature, being 10–40 mg/mL for STH and 10–80 μM for 
5-FU. The IC50 values for the combined treatment were 9.48 mg/mL for 
STH and 21.34 μM for 5-FU in HCT-116 cells whereas in LoVo cells the 
IC50 values were 35.12 mg/mL for STH and 50.11 μM for 5-FU (Table 1). 
In order to investigate the synergistic (CI < 1) or antagonistic (CI > 1) 
effects of STH, various STH+5-FU combinations were used to find out 
the IC50 values of the combined treatment. We found that 6 mg/mL STH 
and 10 μM 5-FU induced 26% and 33% cytotoxicity in HCT-116 cells, 
while the combined treatment induced 50% toxicity, which is same than 
that obtained with 21.34 μM 5-FU (Table 1). Furthermore, in LoVo cells, 
15 mg/mL STH and 20 μM 5-FU induced 19% and 44% cytotoxicity, the 
combined treatment induced 50% toxicity, which is the same that found 
with 50.11 μM 5-FU (Table 1). All the IC50 concentrations were selected 
for further experimental analysis after 48 h of incubation. 
3.2. STH potentiates 5-FU-induced oxidative stress in colon cancer cells 
Tali® Image-Based cytometer was used for measuring intracellular 
ROS production after the treatment with STH and/or 5-FU in HCT-116 
and LoVo cells. IC50 doses significantly increased the ROS levels in 
both colon cancer cells (Fig. 1). 
5-FU induced more ROS compared to STH, while the combined 
treatment was more effective in HCT-116 cells (Fig. 1A). As shown in 
Fig. 1B, the STH treatment induced more ROS production in LoVo cells 
compared to the treatment of 5-FU and 5-FU + STH. 
The main oxidative biomarkers of biomolecules, lipid (TBARS) and 
protein (protein carbonyl content, PCC) were further determined by the 
spectrophotometer method. In HCT-116 cells, STH significantly 
increased the production of TBARS and PCC up to 199% and 164%, 
while 5-FU enhanced more percentage of TBARS (228%) and PCC 
(253%), but the STH+5-FU treatment was slightly less effective 
compared to 5-FU alone (Fig. 1C). A similar trend was observed in LoVo 
cells: for example, STH and 5-FU treatment increased the levels of 
TBARS (212% and 278%) and PCC (211% and 280%), while the com-
bined treatment was less effective, respectively compared to 5-FU 
Table 1 
Cytotoxic activities of 5-FU alone or 48 h treated with STH in HCT-116 and LoVo 
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The IC50 value indicates a concentration of each treatment which caused 50% 
reduction in cell viability based on MTT assay. Each value is expressed as mean 
± standard deviation (SD) of three replicates of three independent experiments. 
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(Fig. 1D). 
3.3. The combination effect of STH and 5-FU on antioxidant enzyme 
activity and the expression 
We further observed the expression and activity of antioxidant en-
zymes after the treatment with STH, 5-FU and STH+5-FU in HCT-116 
and LoVo cells. As shown in Fig. 2, STH and 5-FU significantly 
decreased SOD-1 (72% and 57%), CAT (42% and 48%), GPx (49% and 
43%), GR (57% and 60%) and GST (62% and 69%) activity in HCT-116 
cells, whereas the STH+5-FU decreased the above activity of 61%, 51%, 
35%, 54% and 45%, respectively. 
Additionally, in LoVo cells, STH and 5-FU decreased 67% and 41% 
activity for SOD-1, 52% and 39% activity for CAT, 33% and 61% activity 
for GPx, 55% and 40% activity for GR and 54% and 49% activity for 
GST, respectively; these activities were reduced 46%, 57%, 39%, 44% 
and 47% after the combined treatment (Fig. 2B). 
The treatment with STH and 5-FU suppressed the expression of Nrf2 
and its downstream targets SOD-1, CAT and HO-1 by 0.57 and 0.77 fold, 
0.51 and 0.80 fold, 0.41 and 0.78 fold, 0.72 and 0.75 fold in HCT-116 
cells (Fig. 2C) and by 0.50 and 0.87 fold, 0.69 and 0.66 fold, 0.67 and 
0.85 fold, and 0.70 and 0.84 fold, respectively in LoVo cells (Fig. 2D). In 
both cells, STH suppressed more compared to 5-FU, while in STH+5-FU 
group, the inhibitory effects were more prominent: for Nrf2 0.56 and 
0.36 fold, for SOD-1 0.50 and 0.35 fold, for CAT 0.35 and 0.57 fold, for 
HO-1 0.55 and 0.49 fold, in HCT-116 and Lovo cell lines, respectively 
(Fig. 2C and D). 
3.4. The combination effect of STH and 5-FU on ER stress and 
inflammation 
Due to excess ROS and oxidative stresses, the expression of ER stress 
markers ATF-6 and XBP-1 significantly increased after the treatment 
with STH and/or 5-FU (Fig. 3). In HCT-116 cells, STH and 5-FU 
increased ATF-6 (1.63-fold and 1.82-fold) and XBP-1 (2.51 fold and 
1.53 fold) expression but the combined treatment induced more effects 
in ATF-6 (1.86 fold), while in XBP1 (2.05 fold), it was less effective 
(Fig. 3A). Moreover, in LoVo cells, the expression of ATF-6 and XBP-1 
increased 1.72-fold and 1.97-fold after STH and 1.68 fold and 1.71 
fold after 5-FU, but the STH+5-FU significantly increased both proteins 
of 2.05 fold and 1.95 fold, respectively compared to single compound 
(Fig. 3B). Similarly, the expression of NF-кB and p-IкBα was suppressed 
after each treatment in both cell lines, while the combined treatment 
suppressed more the expression of NF-кB and a similar trend was 
observed in p-IкBα expression after the treatment with STH, 5-FU and 
STH+5-FU, respectively (Fig. 3A and £b). 
3.5. The combination effect of STH and 5-FU on cell cycle in colon cancer 
cell lines 
Cell cycle alteration in HCT-116 and LoVo cells treated with STH 
and/or 5-FU were evaluated. In HCT-116 cells, the treatment with STH, 
5-FU and STH+5-FU induced a significant arrest at the S phase by 
accumulating 54%, 50% and 61% of cells, respectively (Fig. 4A). 
Furthermore, in LoVo cells, the cells were accumulated in G2/M 
phase by 24%, 30% and 31% after the exposure to STH, 5-FU and 
STH+5-FU, respectively (Fig. 4B). 
Fig. 1. STH sensitizes colon cancer cells to 5-FU induced oxidative stress. HCT-116 and LoVo cells were treated with STH alone or in combination with 5-FU. ROS 
generation in (A) HCT-116 and (B) LoVo cells was determined by Tali™ Image-based Cytometer. Results are expressed as % compared to control cells. Blue cells 
correspond to live cells, while red cells correspond to ROS-induced cells. TBARS and protein carbonyl content were measured in (C) HCT-116 and (D) LoVo cells. 
Results were measured as mmol/mg of protein and expressed as % compared to control cells. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. Scale bar 50 μm. 
(For interpretation of the references to colour in this figure legend, the reader is referred to the Web version of this article.) 
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To further discover the molecular mechanisms involved in cell cycle 
arrest by STH and 5-FU alone or in combination, we examined the 
mRNA levels of cyclin-dependent kinases (CDK2 and CDK4), cycle reg-
ulatory proteins (cyclin D1 and cyclin E), cyclin-dependent kinase in-
hibitor (p21waf1/Cip1 and p27kip1) and p-retinoblastoma (p-Rb) at 48 
h. In HCT-116 cells, all the treatments significantly decreased the levels 
of cyclin D1, cyclin E, CDK2, CDK4 and p-RB and the levels of p21Cip 
and p27Kip were increased, whereas the combined treatment induced 
more prominent effects (Fig. 4C). In LoVo cells, we did not observe any 
alteration of cyclin E, CDK2 and CDK4 mRNA levels, while cyclin D1 and 
p-Rb levels were suppressed similarly after the treatment of 5-FU and 
STH+5-FU and the levels of p21Cip and p27Kip increased slightly more 
after 5-FU compared to STH+5-FU, respectively (Fig. 4D). 
3.6. The combination effect of STH and 5-FU on apoptosis in colon cancer 
cells 
The Annexin V/PI staining was used for determining the apoptotic 
effects of STH and/or 5-FU in HCT-116 and LoVo cells with Tali™ 
Image-based Cytometer. The number of apoptotic cells was significantly 
increased after the treatment of STH (2.25 fold for HCT-115 and 3.31 
fold for LoVo), 5-FU (5.49 fold for HCT-115 and 4.55 fold for LoVo) and 
STH+5-FU (3.89 fold for HCT-115 and 5.50 fold for LoVo), respectively, 
being the combined treatment remarkably effective in LoVo cells 
(Fig. 5A and B). 
At the same time, each treatment significantly decreased the number 
of live cells and increased dead cells number. 
To deeply investigate the molecular mechanism involved in 
apoptotic induction, we examined the mRNA expression of both intrinsic 
and extrinsic apoptotic markers (Fig. 5). In both cell lines, the combi-
nation induced a significant increase in p53 and c-PARP, while caspase-3 
levels were similar in 5-FU and STH+5-FU (Fig. 5C and D). The 
expression of intrinsic apoptotic markers, Bax/Bcl2, Cyto C and caspase- 
9, were increased more after the combined treatment compared single 
compound in LoVo cells (Fig. 5F), while in HCT-116 cells the 5-FU 
increased more expression of Bax/Bcl2 and caspase-9 (Fig. 5E). 
Fig. 2. Antioxidant enzymes activity and expression after the treatment with STH alone or in combination with 5-FU. SOD-1, CAT, GPx, GR and GST activities were 
measured as unit/mg protein and expressed as % compared to control cells in (A) HCT-116 and (B) LoVo cells. The protein expression of Nrf2, SOD-1, CAT and HO-1 
was detected by western blotting (normalized to GADPH loading control) in (C) HCT-116 and (D) LoVo cells. Results are expressed as fold change compared to 
control cells. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. 
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Furthermore, the extrinsic apoptotic markers, FasL and caspase-8 
increased similarly after the treatment of 5-FU and STH+5-FU in both 
cell lines, while in HCT-116 cells, 5-FU induced more expression of 
caspase-8 (Fig. 5G and H). Apoptotic effects were also confirmed by 
examining the protein expression of p53, c-PARP and caspase-3 (Fig. 5E 
and F). Each treatment significantly increased the expression of these 
proteins, whereas the combined treatment was more effective in the 
expression of c-PARP and caspase-3 in both cell lines (Fig. 5E and F). 
3.7. STH enhances the anti-proliferative activity of 5-FU by regulating 
EGFR and MAPK signaling pathways 
STH synergistically enhanced the effect of 5-FU on EGFR signaling 
pathways (Fig. 6): the expression levels of EGFR, HER2, p-Akt and p- 
mTOR were performed to evaluate the anti-proliferative effects of STH, 
5-FU and STH+5-FU in HCT-116 and LoVo cells. 
Compared to control, all treatments significantly suppressed the 
expression of the above markers, with the combination inducing more 
effects in both cell lines (Fig. 6A and B). 
Similarly, the expressions of p-p38 MAPK and p-ERK1/2 were eval-
uated. As Fig. 6C and D illustrated, compared to control cells, all the 
treatments significantly increased the protein expression of p-p38 MAPK 
and p-ERK1/2 in HCT-116, while in LoVo cells, 5-FU induced slightly 
more effects compared to STH+5-FU. 
3.8. The combination effect of STH and 5-FU on metabolic phenotype in 
colon cancer cells 
In our previous part, we already evaluated the metabolic alteration 
exerted by STH treatment in HCT-116 and LoVo cells (Afrin et al., 
2019a). In the present work, we observed the metabolic phenotype 
alteration as well as mitochondrial respiration and glycolysis after 48 h 
of treatment with IC50 of STH, 5-FU and STH+5-FU. As shown in Fig. 7A, 
STH treatment changed the baseline phenotype in the aerobic phase 
compared to the control (energetic state), but the treatment of 5-FU and 
STH+5-FU remarkably changed in the quiescent stage which is meta-
bolically inactive. Moreover, in LoVo cells, all the treatments changed 
the phenotype profile in the quiescent stage compared to the control 
(energetic state) (Fig. 7B). 
We also observed altered mitochondrial respiration after the treat-
ment with STH and 5-FU in HCT-116 and LoVo cells (Fig. 7C and D). 
Similar effects were observed in both colon cancer cells: a decrease of 
ATP production, maximal and space respiratory capacity, and proton 
leak (Fig. 7C and D). However, when we used the combined treatment, 
the effects were more prominent compared to a single compound and in 
LoVo cells STH induced more effects compared to 5-FU (Fig. 7C and D). 
We checked whether STH and/or 5-FU might have any impact also 
on glycolysis. In HCT-116 cells, the treatment with STH and 5-FU 
decreased the glycolysis, glycolysis capacity and reserve and in the 
presence of STH+5-FU, similar effects were observed (Fig. 7E). 
Furthermore, in LoVo cells, the STH+5-FU treatment induced more ef-
fects compared to STH and 5-FU alone (Fig. 7F). 
3.9. STH potentiates the anti-metastatic activity of 5-FU 
The anti-migratory effects of STH and/or 5-FU were performed by 
wound scratch assay. After 48 h of incubation, in HCT-116 cells, STH 
and 5-FU decreased wound closer by 44% and 60%, respectively, while 
combined treatment decreased 62% (Fig. 8A). 
Furthermore, in LoVo cells, STH and 5-FU reduced wound closer 
around 60% and 57%, whereas exposure to STH+5-FU remarkably 
decreased 67% (Fig. 8B). 
In order to further investigate the molecular mechanisms by which 
STH and/or 5-FU induced anti-migratory effects, we observed the pro-
tein expression of invasive (MMP-2 and MMP-9) and epi-
thelial–mesenchymal transition EMT (E-cadherin, N-cadherin and 
β-catenin) markers in HCT-116 and LoVo cells (Fig. 8C and D). The 
combined treatment significantly suppressed the expression of MMP-2 
Fig. 3. STH sensitizes colon cancer cells to 5-FU induced ER stress and inflammation. (A) HCT-116 and (B) LoVo cells were treated with STH and 5-FU alone or in 
combination. The protein expression of ATF-6, XBP1, NF-кB and p-IкBα was detected by western blotting (normalized to GADPH loading control). Results are 
expressed as a fold change in comparison control. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. 
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and MMP-9 compared to STH and 5-FU alone, and in both cancer cells 
similar trend was observed (Fig. 8C and D). The expression of E-cadherin 
was significantly increased after each treatment, whereas in HCT-116 
cells the combined treatment induced more effects (Fig. 8C), and in 
LoVo cells STH, 5-FU and STH+5-FU induced similar effects, respec-
tively compared to control (Fig. 8D). Furthermore, N-cadherin expres-
sion was suppressed in both colon cancer cells and all the treatments 
induced similar effects, with more efficacy in LoVo cells. Similarly, the 
expression of β-catenin was suppressed in both cells: in HCT-116 cells 
the 5-FU and STH+5-FU induced similar effects, while in LoVo cells, 5- 
FU suppressed more compared to STH+5-FU (Fig. 8C and D). 
4. Discussion 
The effectiveness of a single chemotherapeutic agent in the treat-
ment of CRC is partial or incomplete due to chemoresistance or adverse 
side effects. Therefore, the mixture of numerous chemo-sensitizers is 
currently employed in clinics to enhance their efficacy and concurrently 
overwhelm resistance and unwanted reaction (Longley et al., 2003). In 
our previous works (Afrin et al., 2017; Afrin et al., 2019b), we found that 
STH possesses several phenolic compounds, including gallic acid and 
kaempferol, and a good antioxidant activity; additionally, STH dis-
played important anti-cancer effects by modulating diverse molecular 
pathways (Afrin et al., 2019a, 2019b). The chemo preventive effects was 
accompanied by the induction of apoptosis via extrinsic (Fas L and 
caspase-8) and intrinsic (Bax/Bcl2, Cyto C and caspase-9) pathway, 
arresting cell cycles in S and G2/M phase, and modulating several cell 
cycle regulated genes (cyclin D1, cyclin E, CDK2, CDK4, p21Cip, p27Kip 
and p-RB) (Afrin et al., 2019b). Additionally, STH also induced oxidative 
stress by increasing intracellular ROS generation and suppressing anti-
oxidant activities. Suppressed mitochondrial respiration and glycolysis 
were observed after STH treatment: all these effects could be ascribed to 
the high amount of bioactive compounds of SHT as reported in our 
previous study (Afrin et al., 2019a). In this study, we observed that STH 
Fig. 4. Cell cycle analysis after the treatment with STH and 5-FU alone or in combination. Images represent an example of the response of (A) HCT-116 and (B) LoVo 
cells and percentage in each cell cycle phase G1, S and G2/M is presented in the table. The mRNA levels of cyclin D1, cyclin E, CDK2, CDK4, p21Cip, p27Kip and p-Rb 
were analyzed by RT-PCR and the data were normalized by GADPH mRNA levels in (C) HCT-116 and (D) LoVo cells. Results are expressed as fold change compared 
to control cells. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. 
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exhibits an impressive synergistic effect, enhancing the 5-FU activities in 
colon cancer cells by growth reduction, suggesting that STH could 
reduce 5-FU doses limiting undesired reactions and drug resistance. A 
previous study has demonstrated that the potent inhibitory effects of 
5-FU against colon cancer cells are enhanced by the presence of various 
polyphenols, even at very lower doses (Hakim et al., 2014). At the same 
time, chemo-sensitization effect of various honey, such as Manuka 
honey, Tulang honey and Gelam honey are already investigated in rat 
Fig. 5. Apoptosis responses after the treatment with STH and 5-FU alone or in combination. (A) HCT-116 and (B) LoVo cells apoptosis was detected by Tali™ Image- 
based Cytometer after Annexin V Alexa Fluor® 488 and PI staining. Fluorescence images show the apoptotic effect with or without treatment: blue colour represents 
live cells, green colour represents apoptotic cells and red and yellow colours represent dead cells. The mRNA levels of p53, c-PARP, caspase-3 Bax/Bcl2, Cyto C, Fas L, 
caspase-8 and caspase-9 were analyzed by RT-PCR and the data were normalized by GADPH mRNA levels in (C, E) HCT-116 and (D, F) LoVo cells. The protein 
expression of p53, c-PARP and caspase-3 were detected by western blotting (normalized to GADPH loading control) in (G) HCT-116 and (H) LoVo cells. Results are 
expressed as fold change compared to control cells. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. (For interpretation of the references to colour in this figure 
legend, the reader is referred to the Web version of this article.) 
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models of melanoma cancer (Fernandez-Cabezudo et al., 2013) and in 
vitro models of colon cancer (Hakim et al., 2014). Overall, our results are 
in agreement with those obtained in previous studies, in which the IC50 
doses of 5-FU is remarkably reduced in the presence of STH, exerting 
synergistic effects on cell viability assay in colon cancer HCT-116 and 
LoVo cells (Table 1). 
Induction of oxidative stress is one of the most common therapeutic 
strategies of the modern drug discovery system. Elevated ROS has been 
used as effectors for various drugs by damaging cancer cells preferen-
tially through injuries of cell bio-molecules (lipid, protein and DNA) and 
suppressing antioxidant pathways (Gorrini et al., 2013). STH suppressed 
HCT-116 and LoVo cells defence system, by inducing oxidative stress 
through ROS production and increased TBARS and PCC levels, which 
further decreased antioxidant enzyme expression and activity; at the 
same time, it induced protective effects on oxidative stress in non-cancer 
cells, such as human dermal fibroblasts, where it exhibited no toxic ef-
fects until 48 h of treatment up to 40 mg/mL, did not induce intracel-
lular ROS production or any significant changes in TBARS and PCC 
levels, did not affect the activities of the main antioxidant enzymes and 
the energetic metabolism, both in term of glycolysis and mitochondrial 
respiration and promoted the migration ability for healing the wound 
area (Afrin et al., 2019a). In the present work, we found that the IC50 
doses of STH and 5-FU induced oxidative stress, and the combined 
treatment was more effective in HCT-116 cells compared to LoVo cells 
(Figs. 1 and 2). These results are consistent with other studies that 
evaluated the chemo-sensitizing effects of quercetin, gypenosides and 
selenium on ovarian (Li et al., 2014), colon (Kong et al., 2015) and 
melanoma (Fan et al., 2013) carcinoma cells through triggering oxida-
tive stress. 
Enhanced Nrf2 expression also induces resistance of 5-FU and creates 
a favorable condition for CRC growth (X.-Q. Zhao, Zhang, Xia, Zhou and 
Cao, 2015). In our work, the expression of Nrf2 and other antioxidant 
enzymes SOD-1, CAT and HO-1 was suppressed after the treatment with 
STH and 5-FU; 5-FU induced less effects compared to STH, but the 
suppressive activity of 5-FU was increased when it was combined with 
STH at 2-fold less concentration (Fig. 2). In agreement with our results, 
several natural compounds, such as luteolin, apigenin and chrysin, 
suppressed Nrf2 activity and expression for enhancing the sensitivity of 
cancer cells to chemotherapeutic drugs in lung cancer (Tang et al., 2011) 
and liver cancer (Gao et al., 2013a, 2013b) cells. 
Due to excess ROS, the inner mitochondrial membrane is weakened 
and releases Cyto C, while ER releases Ca2+ which activates ER stress 
markers for stimulating apoptotic cell death (Malhotra and Kaufman, 
2007). In the present work, STH and 5-FU induced ER stress through 
increasing ATF-6 and XBP-1 expression, and the combined treatment 
was more effective in LoVo cells (Fig. 3). In colon cancer cells, quercetin 
and p-coumaric acid were able to stimulate ER stress cell death through 
elevating the expression of ATF-6, ATF-4, XBP-1, PERK, eIF2α and 
CHOP, and the fold changes were compared to chemotherapeutic drugs 
(Khan et al., 2016; Sharma et al., 2018), but still now, to the best of our 
knowledge, there is not any study observing the chemo-sensitizing ef-
fects of STH on ER stress. 
Increasing the therapeutic efficacy of 5-FU by targeting the NF-κB 
represents an interesting tool for decreasing the chemoresistance. A 
large number of studies highlighted that natural compounds have the 
ability to overcome the therapeutic resistance by suppressing the 
expression NF-κB (Shakibaei et al., 2015). In the present work, we 
observed that the combined treatment was more effective in suppressing 
the expression of NF-κB, while similar suppressed expressions were 
observed for p-IκBα in both cell lines (Fig. 3). 
The cytotoxic effects exerted by 5-FU is associated with cell cycle 
arrest and apoptosis induction (Longley et al., 2003). The exposure to 
STH and 5-FU induced S phase arrest in HCT-116 cells and G2/M phase 
arrest in LoVo cells (Fig. 4). In HCT-116 cells, STH induced more effects 
compared to 5-FU, while in LoVo cells 5-FU was more effective. 
Furthermore, the arresting ability of 5-FU was increased when it was 
Fig. 6. STH enhances the antitumor activity of 5-FU through regulating EGFR and MAPK signaling. HCT-116 and LoVo cells were treated with STH and 5-FU alone or 
in combination. The protein expressions of EGFR, HER2, p-AKT, p-mTOR, p-p38 MAPK and p-ERK1/2 were detected by western blotting (normalized to GADPH 
loading control) in (A, C) HCT-116 and (B, D) LoVo cells. Results are expressed as a fold change in comparison control. *p < 0.05; **p < 0.01; ***p < 0.001 vs. 
control group. 
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combined with STH, at lower concentrations, in both cell lines (Fig. 4). 
The molecular mechanisms behind the arresting effects were also 
confirmed by mRNA analysis with the suppression of mRNA levels of 
CDK2, CDK4 and cyclin E after STH+5-FU treatment in HCT-116 cells, 
and with the increase of p21Cip and p27Kip and decrease of cyclin D1 
and p-Rb in both cancer cells (Fig. 4). Only a few studies have demon-
strated that the natural compounds have the ability to enhance the 
chemo-sanitizing effects of 5-FU by arresting the cell cycle trough 
modulating different molecular pathways in colon cancer cells 
(González-Sarrías et al., 2015; Kong et al., 2015). For example, in colon 
SW-480 cancer cells, gypenosides enhanced the 5-FU augmented G1 to S 
phase cell cycle arrest whereas suppressed cyclin E and CDK2 expression 
(Kong et al., 2015). Furthermore, the metabolites of ellagic acid and 
5-FU arrested the cell cycle at S and G2/M phase in a panel of colon 
cancer cells, and more prominent effects were observed after the com-
bined treatment of these compounds (González-Sarrías et al., 2015). 
The intrinsic and the extrinsic apoptotic pathways are the two major 
pathways involved in the activation of caspases and protease cascade. 
Flow-cytometry analysis revealed the apoptotic induction after the 
treatment of STH and 5-FU alone or in combination in both cancer cells 
with the combined effect more prominent in LoVo cells (Fig. 5). All the 
treatments remarkably increased both the mRNA and protein expression 
of the main apoptotic markers p53, c-PARP and caspase-3, with the 
combined treatments inducing more expressions (Fig. 5). Additionally, 
the present study also confirmed that STH and/or 5-FU triggered 
apoptosis in HCT-116 and LoVo cells through intrinsic (Bax/Bcle, Cyto C 
and caspase-9) and extrinsic (Fas L and caspase-8) apoptotic pathways 
(Fig. 5). Our results are reliable with previous findings that confirmed 
that natural bioactive compounds increased the therapeutic efficacy of 
anti-cancer drugs through activating apoptosis by targeting different 
molecular pathways, such as p53, caspase-3,-8, -9, Bax, PARP in diverse 
CRC cells, as demonstrated for quercetin (Xavier et al., 2011), ellagic 
acid (González-Sarrías et al., 2015), gypenosides (Kong et al., 2015), 
curcumin (Shakibaei et al., 2015), among other compounds. 
The EGFR/HER2 and PI3K-Akt-mTOR pathways are vital targets for 
colon cancer growth and survival and are correlated with 5-FU che-
moresistance (Misale et al., 2012). The expression of EGFR, HER2, p-Akt 
and p-mTOR were suppressed after the treatment of STH and 5-FU in 
both cancer cells; the combined treatment induced more or similar ef-
fects (Fig. 6). Our results are in agreement with the previous finding that 
highlighted that polyphenols augmented the effects of 5-FU by sup-
pressing phosphorylation of EGFR, HER2, IGR-1R, PI3K-Akt-mTOR in 
HCT-116, HT-29 and SW-480 colon cancer cells and FC13K1ApcMin 
mouse model of CRC (Patel et al., 2010). 
MAPKs pathway plays an important role in regulating the mito-
chondrial related proteins, such as p38 MAPK, ERK1/2 and JNK and 
recent evidence displays the potential relationship between oxidative 
stress and MAPKs in apoptosis (Guo et al., 2016). In the present study, 
we found a significant increase of p-p38 MAPK and p-ERK1/2 in 
HCT-116 and LoVo cells after 5-FU treatment (Fig. 6). Furthermore, in 
the presence of STH, 5-FU induced similar effects at lower concentra-
tions in HCT-116 cells and slightly less effects in LoVo cells (Fig. 6). 
These results are consistent with previous studies that examined the 
chemo-sensitizing capacity of other polyphenols in elevating the ex-
pressions of p-p38 MAPK, p-ERK1/2 as well as p-JNK in different cancer 
models, such as epigallocatechin-3-gallate in hepatoma cancer cells 
(Suganuma et al., 2006) and resveratrol in colon cancer (Mohapatra 
et al., 2011) cells. It has also been evaluated that the activated MAPK 
Fig. 7. STH potentiates the anti-metastatic activity of 5-FU in colon cancer cells. HCT-116 and LoVo cells were treated with STH and 5-FU alone or in combination. 
The ratio between basal OCR and basal ECAR showed the metabolic phenotype in (A) HCT-116 and (B) LoVo cells. OCR was determined by sequential injections of 
oligomycin, 2,4-DNP, and rotenone/antimycin in (C) HCT-116 and (D) LoVo cells. ATP production (ATP p), maximal respiration capacity (Maximal R), spare 
respiration capacity (Spare RC) and proton leak (proton L) were calculated from the XF cell Mito stress test profile. ECAR was determined by sequential injections of 
rotenone, glucose, and 2-DG in (E) HCT-116 and (F) LoVo cells. The parameters shown in the figure (glycolysis, glycolytic capacity and glycolytic reserves) were 
measured according to the kit instruction. *p < 0.05; **p < 0.01; ***p < 0.001 vs. control group. 
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Fig. 8. STH potentiates the anti-metastatic ac-
tivity of 5-FU in colon cancer cells. HCT-116 and 
LoVo cells were treated with STH and 5-FU alone 
or in combination. The wound closure percent-
ages were analyzed by Image J software in (A) 
HCT-116 and (B) LoVo cells. The results were 
expressed as % compared to control. The protein 
expression of MMP-2, MMP-9, E-cadherin, N- 
cadherin and β-catenin were detected by western 
blotting (normalized to GADPH loading control) 
in (C) HCT-116 and (D) LoVo cells. Results are 
expressed as a fold change in comparison control. 
*p < 0.05; **p < 0.01; ***p < 0.001 vs. control 
group.   
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pathway alters the pro and/or anti-apoptotic markers (Bcl2 and Bax) 
which translocate to mitochondria and are responsible for the genera-
tion of ROS, leading to the activation of mitochondria-dependent 
apoptosis (Guo et al., 2016). 
Metabolic phenotype is one of the hallmarks of the modern drug 
discovery system, since uncontrolled metabolism is connected with 
therapeutic resistance (Zhao et al., 2013). Chemoresistant proliferative 
cancer cells maintain their required energy levels through oxidative 
phosphorylation (Denise et al., 2015) or higher aerobic glycolysis (Zhou 
et al., 2012). Previously, we found that STH had a significant impact on 
HCT-116 and LoVo cells metabolism by decreasing mitochondrial 
respiration and glycolysis (Afrin et al., 2019a). In the present work, STH 
enhanced the therapeutic efficacy of 5-FU at 2-fold lower concentration 
by switching quiescent phenotype from energetic phenotype (Fig. 7). 
Additionally, the combined treatment was more efficient in reducing 
mitochondrial respiration and glycolysis, especially in LoVo cells 
(Fig. 7). Moreover, no metabolic changes were observed in non-cancer 
cells after exposure to STH (Afrin et al., 2019b). Overall, these results 
suggested that STH has a significant chemo-sensitizing impact on colon 
cancer cells metabolism. 
The anti-metastatic effects by reducing cell migration, invasion and 
EMT markers expression has been well studied for several natural food 
stuffs or isolated polyphenols but the chemo-sensitizing effects on 
metastatic mechanisms are still elusive. In the present report, 5-FU 
decreased wound closer percentage, and the suppressing activity 
increased when combined with STH in LoVo cells (Fig. 8). Moreover, the 
combination of STH and 5-FU treatment suppressed the MMP-2, MMP-9, 
N-cadherin and β-catenin and elevated N-cadherin expression in both 
cell lines (Fig. 8). Similar effects were observed when standard chemo-
therapy was combined with phytochemicals by inducing anti-metastatic 
effects through suppressing the MMP-9, MMP-13 and EMT markers in 
colon cancer cells (Shakibaei et al., 2015). 
5. Conclusions 
The improvement of chemo-sensitizing effects of 5-FU by natural 
compounds in colorectal cancer has been investigated. The present study 
demonstrated that STH enhances the 5-FU effect in colon cancer cells 
and could lead to fewer effective doses and consequently lower side 
effects. The molecular mechanisms were associated with the suppression 
of proliferative markers EGFR, HER2, p-Akt and p-mTOR expression; 
elevated p-p38 MAPK and p-ERK1/2 were observed for apoptosis in-
duction. STH enhanced 5-FU induced cell death by oxidative stress by 
generating ROS and decreasing antioxidant enzyme defence system. The 
arrest in cell cycle and the induction of apoptosis were also confirmed 
after the combined treatment through the regulation of cell cycle genes 
and mitochondrial-dependent and non-dependent apoptotic markers. 
The metabolic phenotypes were significantly altered after the combi-
nation treatment and suppressed migration, invasion and EMT were also 
shown. Overall, this study highlights a new opportunity of using a 
combined treatment of 5-FU and STH for the treatment of colon cancer, 
which needs to be confirmed in animal models to discover the possible 
chemo-sensitizing effects of STH. However, our work has some limita-
tions, including the evaluation of the chemosensitivity with only one 
type of honey or only on in vitro model, the complete lack of the 
assessment of the honey polyphenols stability in culture media or of the 
metabolic transformation, highlighting the necessity to validate our 
results with different approaches by using both in vitro and in vivo 
models. 
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